Hui Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Extracellular vesicles in disease
Papers in
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 21
-
- Circular RNAs in diseases 16
- RNA Research and Splicing 14
- RNA modifications and cancer 13
- Extracellular vesicles in disease 4
- Co-authors
- Kun Lv (21 shared papers)Xiaocen Liu (11 shared papers)Fanfei Kong (9 shared papers)Mingzhe Ma (5 shared papers)Chaxian Liu (1 shared paper)Hao Lin (1 shared paper)Duanwu Zhang (1 shared paper)Ying Qing Mao (1 shared paper)
- Journals
- Frontiers in Pharmacology (4 papers)Journal of Cellular and Molecular Medicine (3 papers)Biochemical and Biophysical Research Communications (3 papers)Cancer Cell International (3 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Yang
114 papers receiving 3.8k citations
Hui Yang's Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 1.1k
- Molecular Biology 1.9k
- Immunology 360
- Oncology 335
- Genetics 132
Countries citing papers authored by Hui Yang
This map shows the geographic impact of Hui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yang more than expected).
Fields of papers citing papers by Hui Yang
This network shows the impact of papers produced by Hui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yang. The network helps show where Hui Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Majorbio Cloud: A one‐stop, comprehensive bioinformatic platform for multiomics analyses Hit paper breakdown → | 2022 | 697 |
| 2 | 2017 | 344 | |
| 3 | Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives Hit paper breakdown → | 2024 | 215 |
| 4 | 2021 | 212 | |
| 5 | 2021 | 81 | |
| 6 | 2014 | 81 | |
| 7 | HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer. | 2016 | 78 |
| 8 | 2021 | 77 | |
| 9 | Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer Hit paper breakdown → | 2024 | 71 |
| 10 | 2020 | 69 | |
| 11 | 2022 | 61 | |
| 12 | 2022 | 60 | |
| 13 | 2005 | 58 | |
| 14 | 2013 | 54 | |
| 15 | 2022 | 54 | |
| 16 | 2018 | 51 | |
| 17 | 2018 | 51 | |
| 18 | 2024 | 48 | |
| 19 | 2024 | 46 | |
| 20 | 2020 | 45 |
About Hui Yang
Hui Yang is a scholar working on Cancer Research, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 120 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (16 papers), RNA Research and Splicing (14 papers), RNA modifications and cancer (13 papers), Ferroptosis and cancer prognosis (8 papers), Glioma Diagnosis and Treatment (5 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.9k citations), Immunology (360 citations), Oncology (335 citations) and Genetics (132 citations). Hui Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kun Lv, Xiaocen Liu, Fanfei Kong, Mingzhe Ma, Chaxian Liu, Hao Lin, Duanwu Zhang, Ying Qing Mao, An-Kang Hu and Zhihao Wu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Cellular and Molecular Medicine, Biochemical and Biophysical Research Communications, Cancer Cell International and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.